Skip to main content
All lobbying clients

QUEST DIAGNOSTICS INCORPORATED

Lobbying client · New Jersey · filed 2025 to 2026

Clinical laboratory testing company.

$4,110,000 Reported spend
28 Filings counted
3 Outside firms hired
18 Bills named

Spend is reported income plus in-house expenses across 28 filings. 3 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 4 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as QUEST DIAGNOSTICS.

 Who filed for this client 4

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 18
  • H.R. 5269
    RESULTS Act
    14 filings
  • S. 2761
    RESULTS Act
    14 filings
  • H.R. 3514
    Improving Seniors’ Timely Access to Care Act of 2025
    6 filings
  • S. 1816
    Improving Seniors’ Timely Access to Care Act of 2025
    6 filings
  • H.R. 5571
    Expanding Seniors’ Access to PFAS Testing Act
    5 filings
  • H.R. 5582
    Patients Deserve Price Tags Act
    4 filings
  • S. 2355
    Patients Deserve Price Tags Act
    4 filings
  • H.R. 6363
    Further Continuing Appropriations and Other Extensions Act, 2024
    3 filings
  • H.R. 6130
    ASAP Act
    3 filings
  • H.R. 1
    One Big Beautiful Bill Act
    2 filings
  • H.R. 5444
    Medical Laboratory Personnel Shortage Relief Act of 2025
    2 filings
  • H.R. 7961
    H–1Bs for Physicians and the Healthcare Workforce Act
    2 filings
  • H.R. 8413
    SECURE Data Act
    2 filings
  • H.R. 8890
    Enhancing CLIA Act of 2026
    2 filings
  • H.R. 9393
    Lower Costs, More Transparency Act of 2026
    2 filings
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    1 filing
  • H.R. 7148
    Consolidated Appropriations Act, 2026
    1 filing
  • S. 891
    Bipartisan Health Care Act
    1 filing
 Reported by year 2 years
  • 2026 $2,030,000 12 filings
  • 2025 $2,080,000 16 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 28
  • SENATE 28
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Health & Human Services, Dept of (HHS) 6
 Recent filings 31 total
Q3 report
FEDERAL STREET STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
QUEST DIAGNOSTICS INCORPORATED
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $300,000 expenses · posted Oct 20, 2026
View →
Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
RED+BLUE STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View →
Q2 report
FEDERAL STREET STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
QUEST DIAGNOSTICS INCORPORATED
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $470,000 expenses · posted Jul 20, 2026
View →
Q2 report
RED+BLUE STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 17, 2026
View →
Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 16, 2026
View →
Q1 report
FEDERAL STREET STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 20, 2026
View →
Q1 report
RED+BLUE STRATEGIES
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026
View →
Q1 report
TARPLIN, DOWNS & YOUNG, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View →
Q1 report
QUEST DIAGNOSTICS INCORPORATED
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $690,000 expenses · posted Apr 20, 2026
View →
Q4 report
FEDERAL STREET STRATEGIES, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View →
Q4 report
TARPLIN, DOWNS & YOUNG, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View →
Q4 report
RED+BLUE STRATEGIES
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,000 income · posted Jan 20, 2026
View →
Q3 amendment
QUEST DIAGNOSTICS INCORPORATED
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $310,000 expenses · posted Jan 20, 2026
View →
Q2 amendment
QUEST DIAGNOSTICS INCORPORATED
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $330,000 expenses · posted Jan 20, 2026
View →
Q1 amendment
QUEST DIAGNOSTICS INCORPORATED
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $330,000 expenses · posted Jan 20, 2026
View →
Q4 report
QUEST DIAGNOSTICS INCORPORATED
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $350,000 expenses · posted Jan 20, 2026
View →
Q3 report
FEDERAL STREET STRATEGIES, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View →

Showing the 20 most recent of 31 filings. Search the explorer for "QUEST DIAGNOSTICS INCORPORATED".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem